Research Catalog · peptide family
Survivin (Apoptosis Inhibitor, BIRC5) — Research Products
4 catalog items
| Catalog # | Product | Type | Species | Size | Price | Add to cart |
|---|---|---|---|---|---|---|
| 001-51 | [Cys0]-Survivin / Apoptosis Inhibitor (123-142) (Human) | Peptides | Human | 100 µg | $360.00 | |
| 001-08 | Survivin / Apoptosis Inhibitor (17-34) (Human) | Peptides | Human | 200 µg | $209.00 | |
| 001-09 | Survivin / Apoptosis Inhibitor (84-110) (Human) | Peptides | Human | 200 µg | $284.00 | |
| 001-11 | Survivin 2B (80-88) (Human) | Peptides | Human | 200 µg | $192.00 |
All items are supplied for in vitro laboratory research use only — not for human or veterinary use, diagnosis or therapy. Prices are per unit as listed; each catalog number ships with its Certificate of Analysis.
Survivin (Apoptosis Inhibitor, BIRC5) — frequently asked
What is survivin?
Survivin is the smallest inhibitor of apoptosis family protein, encoded by BIRC5. It carries a single baculoviral IAP repeat domain, works as a homodimer, and is reported to act largely through partner interactions rather than direct caspase inhibition.
Why is survivin researched?
It is studied both as a regulator of apoptosis and as a chromosomal passenger complex member involved in mitosis. Its low expression in most adult tissue but high expression in many tumour samples has also made it a frequent subject in oncology and tumour immunology research.
What are the listed peptides used for?
Human fragments such as (17-34), (84-110) and the cysteinylated (123-142) peptide serve as immunogens, blocking peptides and antibody validation controls. The shorter survivin 2B (80-88) sequence is a defined epitope peptide used in cellular immunology assays.